Lower Cost, Better Care

Immunotherapy: Precision Medicine in Action The importance of keeping the promise and potential of immunotherapy alive

TThe first cancer immunotherapy was approved in 2011; today, there are more than 70 such drugs in the clinical pipeline. By 2020, the cancer treatment industry is expected to achieve $16.55 billion dollars in revenue. Read our policy brief to learn more about milestones in cancer immunotherapy.

As the cost of health care in the United States continues to rise, of utmost concern are reports that medical bills are creating substantial hardships for patients. Health care debt is now the leading contributor to individual bankruptcy and home foreclosures. Both insured and uninsured patients are burdened by medical bills. And health care quality and safety are compromised as people avoid even the most basic and necessary care because of cost. Health care providers are in a unique position to lead the transition to value-based care. Medical providers and professional societies across the country are working to reduce use of unnecessary tests, procedures and treatments that increase patients’ financial burdens without adding value to their care. 

Wednesday, September. 27, from 9 to 10:30 a.m.
Senate Visitors Center, Room 201-00
Washington, D.C. 20045

Experts Discuss Lower Cost, Better Care

Paul Rothman, M.D., leads a panel of experts in discussion about how to provide better care while reversing the course of crushing medical costs. Panelists examine the role that medical systems, insurers, patients, physicians and caregivers play in turning the tide and how can Capitol Hill can help.

 

Moderator

 

Paul Rothman
Dean of the Medical Faculty
CEO of Johns Hopkins Medicine

 

Panelists

Michael Kanter
Executive Vice President of Quality and Chief Quality Officer, The Permanente Federation
Medical Director, Quality and Clinical Analysis, Southern California Permanente Medical Group

Curt Medeiros
President, Optum Life Sciences at UnitedHealth Group

Peter Pronovost
Senior VP for Patient Safety and Quality, Johns Hopkins Medicine
Director, Armstrong Institute for Patient Safety and Quality

Lisa Simpson
President and CEO, AcademyHealth
@DrSimpsonHSR

Follow the discussion on @HopkinsinHealth and #HopkinsOntheRoad.